4//SEC Filing
Kim Bobae 4
Accession 0001104659-23-063263
CIK 0001600132other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:51 PM ET
Size
12.6 KB
Accession
0001104659-23-063263
Insider Transaction Report
Form 4
Kim Bobae
VP Reg. Affairs & Quality
Transactions
- Exercise/Conversion
Common Stock
2023-05-18$7.35/sh+266$1,955→ 1,723 total - Exercise/Conversion
Common Stock
2023-05-18$7.50/sh+1,022$7,665→ 1,723 total - Sale
Common Stock
2023-05-18$10.00/sh−9,455$94,550→ 1,723 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-05-18−266→ 0 totalExercise: $7.35Exp: 2026-12-07→ Common Stock (266 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2023-05-18−1,022→ 144 totalExercise: $7.50Exp: 2029-09-26→ Common Stock (1,022 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.26, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F2]The shares subject to this option are fully vested and exercisable.
- [F3]This option was granted on September 26, 2019. This option vests in quarterly installments over a four-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001959158
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 6:51 PM ET
- Size
- 12.6 KB